Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHemogenyx Share News (HEMO)

Share Price Information for Hemogenyx (HEMO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.60
Bid: 1.586
Ask: 1.63
Change: -0.021 (-1.29%)
Spread: 0.044 (2.774%)
Open: 1.698
High: 1.70
Low: 1.60
Prev. Close: 1.629
HEMO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK TRADING UPDATE SUMMARY: Novacyt Virus Test Orders At EUR135 Million

Tue, 02nd Jun 2020 12:57

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

----------

Novacyt SA - clinical diagnostics - Says sales of Covid-19 tests totalling EUR135 million at June 1, including EUR45 million already received and forward orders worth an additional EUR90 million. Novacyt says it is selling testing kits to more than 130 countries and wins Zimbabwe contract to supply 1.5 million tests.

----------

Concepta PLC - pregnancy testing and fertility tracking - Reports cost savings made as a result of manufacturing of myLotus fertility tracking product being outsourced. Says in early stages of commercial rollout of myLotus, but announces plans for digital campaign in June.

----------

Hemogenyx Pharmaceuticals PLC - blood disease treatment - Extends development deal with an unnamed global pharmaceutical company due to Covid-19. Partnership to develop CDX antibody candidate extended by three months to complete work.

----------

ValiRx PLC - cancer treatment - To work with Oncolytika Ltd and Black Cat Bio Ltd to explore use of VAL201 in a combination treatment for severe SARS-Cov2 sufferers. ValiRx cautions no guarantee collaboration will result in licensing income.

----------

PureTech Health PLC - biotherapeutics - Says founding entity Gelasis receives approval to market Plenity weight loss treatment in Europe.

----------

Braveheart Investment Group PLC - investment company - Says 80% owned Kirkstall Ltd partnering with Animal Free Research UK, researchers awarding grants to scientists who use techniques to replace use of animals in trials. Says Animal Free Research panel awards outlines projects that will use Kirkstall's Quasi Vivo system in Covid-19 research.

----------

Witan Investment Trust PLC - investor - Says performance so far in 2020 hurt by Covid-19 volatility, with total return at negative 17%, underperforming benchmark which gained 5%. Says UK stocks particularly hit, losing 19% in the period to end of May.

----------

Rambler Metals & Mining PLC - copper and gold producer - Enters into short-term financing agreement with Aether Real Assets Co Investment for GBP1.0 million unsecured loan carrying 10% annual interest, maturing October 5.

----------

Volga Gas PLC - oil and has exploration and production - Says average May production came in an 3,372 barrels of oil equivalent per day, up 45% month-on-month. Adds average price hurt by devaluation of Russian ruble and wider oil price drop.

----------

Ascent Resources PLC - natural resources - Says Slovenian environmental agency has announced Ascent's joint-venture partner Geoenergo doo needs impact assessment before working on PG-10 and PG-11A wells.

----------

Clipper Logistics PLC - logistics - Expects to report full-year earnings before interest, taxes and amortisation of roughly GBP24.0 million, a 19% rise. Reports boosted levels of activity from new and existing customers following initial Covid-19 disruption. Expects EBITA in financial 2021 to beat company-compiled consensus of GBP25.8 million.

----------

Hargreaves Services PLC - industrial and property services - To halt all coal mining operations by July 2020, but will incur GBP3.7 million exceptional cost for year ended May 31, 2020 as a result. Says no material disruption from Covid-19 besides in Property business, where work at a residential site near Edinburgh was suspended.

----------

Quartix Holdings PLC - vehicle tracking - Says trading during the four months to April 30 was stronger year-on-year. Does report however that new fleet installations fell 60% year-on-year in April and 25% annually in May, despite slight rebound as lockdowns eased. Says no material impact on subscription base as a result of Covid-19. Adds pandemic is unlikely to have material impact on profit and cash flow for first half of 2020.

----------

Zotefoams PLC - foam products maker - Maintained operations in April and May, despite challenging demand conditions. Expects trading in the second quarter to be in line with board expectations and forecasts stronger second half.

----------

Water Intelligence PLC - water leak detection - Reacquires San Jose, California franchise to sit within American Leak Detection subsidiary. Allows company to have corporate base in Silicon Valley, offering chance to build on "strong" research and development relationships.

----------

Gusbourne PLC - sparkling wine maker - Says 2020 started strongly but distribution channels hit by Covid-19 since March, though online demand has increased. Winery and vineyards continued production through lockdown, but company has furloughed staff, particularly in sales team. Enters into GBP10.5 million facility with lender PNC Financial Services UK Ltd. Gusbourne says new agreement will refinance existing debts.

----------

Blancco Technology Group PLC - data erasure - Enters in master service agreement to provide Aon Group Co with device diagnostics technology.

----------

Gaming Realms PLC - mobile games - Says licensing revenue continued to grow, surging 80% year-on-year between April and May. Adds revenue helped by new licensing partners like 888casino.com, Sky Betting & Gaming and Draft Kings. Expects earnings before interest, taxes, depreciation and amortisation for 2020 to be significantly ahead of market expectations.

----------

WANdisco PLC - Data and AI - Says it has secured reseller agreement with "large global systems integrator". Reports customer will have access to WANdisco's suite of solutions.

----------

Boku Inc - mobile payments platform - Reports identity services now available in more than 50 countries.

----------

Toople PLC - telecoms - Reports recently-acquired subsidiary Direct Market Services Ltd wins pact to provide IT services to Carluccio's restaurant group.

----------

Iconic Labs PLC - media business - To issue 500.0 million new shares under first tranche of convertible bonds agreement with lender.

----------

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
29 Feb 2024 14:04

Hemogenyx Pharmaceuticals raises money for leukaemia treatment

(Alliance News) - Hemogenyx Pharmaceuticals PLC on Thursday said it has raised GBP3.3 million through a placing.

Read more
16 Feb 2024 11:27

Hemogenyx shares rise on potential for CBR to treat brain diseases

(Alliance News) - Hemogenyx Pharmaceuticals PLC on Friday said research has shown that its proprietary chimeric bait receptor can be delivered into the brain through programmed microglial cells and could be used for the treatment of brain cancers and some neurodegenerative diseases.

Read more
14 Feb 2024 10:14

Hemogenyx says CBR can be used intranasally to treat viral infections

(Alliance News) - Hemogenyx Pharmaceuticals PLC on Wednesday said its chimeric bait receptor can be delivered intranasally in the form of messenger RNA for the "potential" treatment of airborne viral infections.

Read more
9 Feb 2024 10:00

IN BRIEF: Hemogenyx shares surge as FDA lifts Hemo-Car-T trial hold

Hemogenyx Pharmaceuticals PLC - London-based biopharmaceutical company focused on treatments for deadly blood diseases - US Food & Drug Administration has lifted clinical hold on company's investigational new drug application for Hemo-Car-T to treat acute myeloid leukemia. FDA placed therapy on clinical hold in July due to a splicing deficiency during manufacture of the lentivirus used to produce Car-T cells. Hemogenyx in August produced a "detailed plan, supported by laboratory tests" to address FDA's concerns, which was accepted the following month.

Read more
2 Feb 2024 10:44

IN BRIEF: Hemogenyx hails US patent application progress

Hemogenyx Pharmaceuticals PLC - London-based biopharmaceutical company focused on treatments for deadly blood diseases - Celebrates as patent application is allowed by the US Patent & Trademark Office. The patent is for the process of eliminating hematopoietic stem cells or hematopoietic progenitors in a patient using bi-specific antibodies.

Read more
16 Jan 2024 11:13

Hemogenyx Pharmaceuticals sends complete response on HEMO-CAR-T to FDA

(Alliance News) - Hemogenyx Pharmaceuticals PLC on Tuesday said it submitted a complete response to the previously announced clinical hold of the investigational new drug application to the US Food & Drug Administration.

Read more
8 Jan 2024 10:56

Hemogenyx Pharmaceuticals completes process qualification run

(Alliance News) - Hemogenyx Pharmaceuticals PLC on Monday said it completed a process qualification run.

Read more
28 Nov 2023 16:53

TRADING UPDATES: Upland Resources completes technical study at Sarawak

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
27 Nov 2023 10:52

Hemogenyx shares up as says CBR platform a potential cancer treatment

(Alliance News) - Hemogenyx Pharmaceuticals PLC on Monday said its chimeric based receptor platform could "potentially" be used to treat cancer and viral diseases.

Read more
15 Nov 2023 15:43

Hemogenyx Pharmaceuticals completes lentivirus re-manufacture

(Alliance News) - Hemogenyx Pharmaceuticals PLC on Wednesday said it has completed the re-manufacturing of an improved lentivirus devoid of splice variants.

Read more
28 Sep 2023 14:24

EARNINGS: Dar Global profit multiplies, Hemogenyx loss widens

(Alliance News) - The following is a round-up of earnings updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
18 Sep 2023 14:37

TRADING UPDATES: Avingtrans buys Adaptix, TPXimpact sells Questers

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
18 Sep 2023 13:00

Hermogenyx shares soar on new partnership with Prevail Partners

(Sharecast News) - Shares in biopharma group Hemogenyx surged on Monday after the company received a $0.83m investment from Prevail Partners as it continues to work on its planned clinical trial for leukaemia treatment.

Read more
14 Sep 2023 14:31

Hemogenyx Pharma says US FDA accepts Hemo-Car-T clinical hold lift plan

(Alliance News) - Hemogenyx Pharmaceuticals PLC on Thursday said the US Food & Drug Administration has accepted its plan to address concerns which sparked a clinical hold on its chimeric antigen receptor T-cell or Hemo-Car-T therapy.

Read more
8 Sep 2023 19:43

IN BRIEF: Hemogenyx Pharmaceuticals says patent number published

Hemogenyx Pharmaceuticals PLC - London-based biopharmaceutical group developing new therapies and treatments for blood diseases - Says its patent application number "WO2023168292 Chimeric Bait Receptors and Uses Thereof" was published by the World Intellectual Property Organization on Thursday. Says it remains to be reviewed and approved by national patent authorities.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.